Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
![](../../images/overlap_matrix_icon.png)
30
Number of overlapping holdings
60.0%
% of FTXH's 51 holdings also in XBI
23.3%
% of XBI's 129 holdings also in FTXH
Overlap by Weight
Sector Drift (FTXH minus XBI)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
Company | Weight in FTXH |
Weight in XBI |
Overlap | |
---|---|---|---|---|
UNITED THERAPEUTICS CORP | 4.9% | 3.2% | 3.2% | |
GILEAD SCIENCES INC | 3.7% | 3.0% | 3.0% | |
ABBVIE INC | 7.4% | 2.9% | 2.9% | |
REGENERON PHARMACEUTICALS | 4.1% | 2.9% | 2.9% | |
AMGEN INC | 4.1% | 2.8% | 2.8% |
Position Highlights (Non-Overlapping Exposures)
FTXH Overweight Relative to XBI
PFIZER INC | 7.3% | |
JOHNSON & JOHNSON | 6.9% | |
BRISTOL-MYERS SQUIBB CO | 6.6% | |
MERCK & CO. INC. | 6.2% | |
ABBVIE INC | 4.5% | |
ELI LILLY & CO | 4.3% | |
CARDINAL HEALTH INC | 3.4% | |
VIATRIS, INC. | 3.3% | |
ZOETIS INC | 3.1% | |
ORGANON & CO. | 2.9% |
FTXH Underweight Relative to XBI
EXACT SCIENCES CORP | -3.2% | |
ALNYLAM PHARMACEUTICALS INC | -2.9% | |
NATERA INC | -2.6% | |
VIKING THERAPEUTICS, INC. | -2.5% | |
BIOMARIN PHARMACEUTICAL INC | -2.2% | |
SAREPTA THERAPEUTICS INC | -2.2% | |
CYTOKINETICS INC | -2.0% | |
INCYTE CORP | -1.5% | |
MODERNA, INC. | -1.4% | |
NEUROCRINE BIOSCIENCES INC | -1.3% |